infliximab
Subcutaneous Infliximab Found Effective With or Without an Immunosuppressant
Patients who achieved a clinical response to subcutaneous infliximab showed no meaningful differences in outcomes ...
APRIL 28, 2025
FDA Approves Zymfentra for IBD
The FDA approved Zymfentra for the treatment of inflammatory bowel disease.
OCTOBER 27, 2023
Ixifi, a Biosimilar for RA, Receives Approval
FDA approves another biosimilar for Remicade. Ixifi has all of the same indications.
DECEMBER 14, 2017
FDA Approves Second Biosimilar of Remicade
Renlexis, a TNF blocker, will be indicated for the treatment of adult and pediatric Crohn’s disease, adult ...
APRIL 24, 2017
FDA Panel Recommends Approval for Second Biosimilar
Based on the biological similarity o the innovator product, the panel endorsed its use for the all the indications ...
FEBRUARY 10, 2016
